Skip to main content
SpringerLink
Log in

Chronic kidney disease

Blood pressure control in CKD—still a matter of debate

  • News & Views
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

A new meta-analysis reports that intensive blood pressure lowering reduces the risk of kidney failure in patients with chronic kidney disease and albuminuria. However, the level of blood pressure control required for optimum protection of the cardiovascular and renal systems remains unclear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lv, J. et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ 185, 949–957 (2013).

    Article  Google Scholar 

  2. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. Suppl. 2, 337–414 (2012).

  3. American Diabetes Association. 2013 Clinical Practice Recommendations. Diabetes Care 36 (Suppl. 1), S1–S110 (2013).

  4. Mancia, G. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). J. Hypertens. 31, 1281–1357 (2013).

    Article  CAS  Google Scholar 

  5. Ruilope, L. M. & Bakris, G. L. Renal function and target organ damage in hypertension. Eur. Heart J. 32, 1599–1604 (2011).

    Article  Google Scholar 

  6. Dahlöf, B. et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised control trial. Lancet 366, 895–906 (2005).

    Article  Google Scholar 

  7. De Galan, B. E. et al. Lowering blood pressure reduces renal events in type 2 diabetes. J. Am. Soc. Nephrol. 20, 883–892 (2009).

    Article  CAS  Google Scholar 

  8. Jamerson, K. et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high risk patients. N. Engl. J. Med. 359, 2417–2428 (2008).

    Article  CAS  Google Scholar 

  9. Parving, H. H. et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N. Engl. J. Med. 367, 2204–2213 (2012).

    Article  CAS  Google Scholar 

  10. Gorostidi, M. et al. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: a 5,693-patient cross-sectional analysis from Spain. Am. J. Kidney Dis. 62, 285–294 (2013).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unidad de Hipertension, Hospital 12 de Octubre, Avenida Cordoba s/n, Madrid, 28041, Spain

    Luis M. Ruilope

Authors
  1. Luis M. Ruilope
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruilope, L. Blood pressure control in CKD—still a matter of debate. Nat Rev Nephrol 9, 572–573 (2013). https://doi.org/10.1038/nrneph.2013.180

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2013.180

  • Springer Nature Limited

This article is cited by

Search

Navigation